Rabenhorst et al. found that the human p21 promoter had four potential FUBP1 binding sites within 3.2 kb upstream of its transcription start site, and demonstrated that FUPB1 was bound to the p21 promoter and directly regulated its activity in HCC [24]. Here, FUBP1 is linked to hepatocellular carcinoma.